PedAM
Pediatric Disease Annotations & Medicines
| Disease | thrombocytopenia |
| Phenotype | C0024299|lymphomas |
| Sentences | 1 |
| PubMedID- 26501980 | Since cd22 is a b-lymphocyte-restricted phosphoglycoprotein [184], inotuzumab ozogamicin has been clinically examined in b-cell leukemias and lymphomas with reversible thrombocytopenia as the main toxicity observed. |
Page: 1